Filing Flows › BioMarin Pharmaceutical (BMRN) › Q2 2026
BioMarin Pharmaceutical (BMRN) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
BioMarin Pharmaceutical (BMRN) reported revenue of $990M for the second quarter 2026 (Q2 2026), +20% from a year earlier and +29% from the quarter before. Operating margin was 11.2%, net earnings $44.8M (4.5% of revenue).
BioMarin Pharmaceutical, Q2 2026: revenue $990M (+20% year over year), operating margin 11.2%, net earnings $44.8M, operating cash flow $168M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $990M | +29% | +20% |
| Operating profit | $111M | -14% | -60% |
| Net earnings | $44.8M | -58% | -81% |
| Operating cash flow | $168M | -24% | -9% |
| Free cash flow | $139M | -30% | -17% |
What changed
Revenue was $989.7M in Q2 2026, up 20% year over year and up 29% from the previous quarter. VOXZOGO was the largest line at 26% of revenue. VOXZOGO added $31.1M year over year (up 14%), 19% of the total change. Royalty and other revenues declined 57%.
Operating profit was $110.9M, a 11.2% margin (down 22.3 points year over year). Operating profit fell $166.0M even though revenue rose $164.3M versus Q2 2025, so costs grew faster than sales. Total costs grew 60% against revenue growth of 20%. The fastest-growing cost line was Other operating costs (+1417%). Net earnings were $44.8M, down 81% year over year. The effective tax rate was 27.1%.
Operating cash flow was $168.1M (down 9% year over year), 376% of net earnings. Non-cash charges added back $97.6M of depreciation and amortization and $75.7M of share-based compensation. Working capital and other items used $50.0M. Capital expenditures of $28.8M left free cash flow of $139.3M.
Questions
What was BioMarin Pharmaceutical's revenue in the second quarter 2026?
BioMarin Pharmaceutical (BMRN) reported revenue of $990M for the second quarter 2026 (Q2 2026), +20% from a year earlier and +29% from the quarter before.
Was BioMarin Pharmaceutical profitable in the second quarter 2026?
Operating profit was $111M (11.2% of revenue) and net earnings $44.8M.